Teladoc Acquires Livongo in $18.5 Billion Deal

Paul, Weiss advised Teladoc Health, the global leader in virtual care, in its acquisition of Livongo, the leading Applied Health Signals company, in a cash-and-stock deal valued at $18.5 billion. The combination of these highly complementary leaders in virtual care and chronic condition management represents a transformational opportunity to improve the delivery, access and experience of healthcare worldwide.

Immediately following the closing of the transaction, Teladoc shareholders owned approximately 58% of the combined company, while former Livongo shareholders owned the remaining 42%. The combined company is expected to have more than $1.3 billion in pro forma revenue in 2020, representing year-over-year pro forma growth of 85%.

The Paul, Weiss team included, among others, corporate partners Scott Barshay, Laura Turano, Manuel Frey and John Kennedy, and counsel Patricia Vaz de Almeida; intellectual property partner Jonathan Ashtor; tax partner Robert Holo; employee benefits partner Jean McLoughlin and counsel Jarrett Hoffman; real estate partner Peter Fisch; litigation partner Audra Soloway and counsel Steven Herzog; and antitrust counsel Yuni Sobel.